HEATHER FESPERMAN: Open Payments
NPI 1891319745 · CORDOVA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,513 in 111 payments from 18 companies in 2025. Trend: 2023 $1,468 · 2024 $1,628 · 2025 $2,513
Food & beverage: $2,513
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $429 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $286 |
| Supernus Pharmaceuticals, Inc. | 8 | $253 |
| Alkermes, Inc. | 9 | $227 |
| Neuronetics, Inc. | 1 | $187 |
| ABBVIE INC. | 11 | $185 |
| Vanda Pharmaceuticals Inc. | 7 | $168 |
| Otsuka America Pharmaceutical, Inc. | 8 | $153 |
| Janssen Pharmaceuticals, Inc | 7 | $144 |
| Axsome Therapeutics, Inc. | 6 | $105 |
Products named: CAPLYTA, TRINTELLIX, Qelbree, REXULTI, ARISTADA, NEUROSTAR TMS THERAPY SYSTEM, VRAYLAR, SPRAVATO.
Industry payments across TN — which companies pay providers there.
